Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04350047
Other study ID # Not appicable
Secondary ID
Status Completed
Phase
First received
Last updated
Start date January 1, 2018
Est. completion date March 31, 2020

Study information

Verified date April 2020
Source Attikon Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Assessment of short-term outcomes of radical nephrectomy combined with IVC thrombectomy with a novel technique without thoracotomy: single center case series.


Description:

Assessment of the 30-day mortality and major complications as well as long-term oncological outcomes of three patients undergoing radical nephrectomy combined with inferior vena cava (IVC) thrombectomy with a novel technique without thoracotomy for renal cell carcinoma with IVC level IV thrombus. This is a retrospective case series carried out at Attikon University Hospital between January 2018 to March 2020.


Recruitment information / eligibility

Status Completed
Enrollment 3
Est. completion date March 31, 2020
Est. primary completion date March 31, 2020
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Adult patients

- Documented radiological and/or pathological diagnosis of renal cell carcinoma with level IV tumor thrombus

Exclusion Criteria:

- American Anesthesia Association (ASA) Class V and/or any contraindications to general anesthesia

Study Design


Intervention

Procedure:
Radical nephrectomy with inferior vena cava thrombectomy without thoracotomy
The abdomen was accessed through a Makuuchi incision. After mobilization of the liver and assessment of the inferior vena cava infiltration (IVC), IVC was clamped below the level of the renal veins. In order to get access to the intrapericardial IVC, an incision was made through the tendon of the diaphragm and a clamp was placed first in the hepatoduodenal ligament (Pringle maneuver) and then in the endopericardial portion of the IVC, in that order. A longitudinal 3-4 cm incision was made incorporating the junction of IVC and right renal vein. After tumor removal thrombus was removed and a fine clamp was placed at the IVC just below the hepatocaval junction and immediate release of the clamping of the hepatoduodenal ligament. Total endopericardial clamp time was 4 minutes. Patients then underwent radical nephrectomy in a standard fashion with en bloc resection of the IVC thrombus.

Locations

Country Name City State
Greece Attikon University Hospital Chaidari

Sponsors (1)

Lead Sponsor Collaborator
Attikon Hospital

Country where clinical trial is conducted

Greece, 

Outcome

Type Measure Description Time frame Safety issue
Primary Short term mortality rate Percentage of patients` postoperative deaths 30 days
Secondary Short term major complications` rate Incidence of Clavien/Dindo grade 3 or more postoperative complications 30 days
Secondary Recurrence rate Rate of local or systemic recurrence 27 months
See also
  Status Clinical Trial Phase
Terminated NCT06377722 - Cabozantinib Treatment Prior to Cytoreductive Nephrectomy in Patients With Advanced or Metastatic Renal Cells Cancer Phase 2